---
title: "Beigene released its performance for the first three quarters, with a net profit attributable to the parent company of 1.139 billion yuan, turning a profit from a loss year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265485916.md"
description: "According to the Zhitong Finance APP, Beigene disclosed its third-quarter report for 2025. The company achieved revenue of 27.595 billion yuan in the first three quarters, a year-on-year increase of 44.2%; the net profit attributable to shareholders of the listed company was 1.139 billion yuan, turning from loss to profit year-on-year; the net profit excluding non-recurring items was 969 million yuan, also turning from loss to profit year-on-year; the basic earnings per share were 0.81 yuan. The growth in performance was mainly due to the increase in product revenue and expense management, which drove improvements in operational efficiency"
datetime: "2025-11-12T09:59:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265485916.md)
  - [en](https://longbridge.com/en/news/265485916.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265485916.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/265485916.md) | [繁體中文](https://longbridge.com/zh-HK/news/265485916.md)


# Beigene released its performance for the first three quarters, with a net profit attributable to the parent company of 1.139 billion yuan, turning a profit from a loss year-on-year

According to the Zhitong Finance APP, Beigene (688235.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 27.595 billion yuan in the first three quarters, a year-on-year increase of 44.2%; the net profit attributable to shareholders of the listed company was 1.139 billion yuan, turning from loss to profit year-on-year; the net profit excluding non-recurring items was 969 million yuan, also turning from loss to profit year-on-year; the basic earnings per share were 0.81 yuan.

The growth in performance was mainly due to the increase in product revenue and expense management, which drove improvements in operational efficiency

### Related Stocks

- [BeOne Medicines AG (ONC.US)](https://longbridge.com/en/quote/ONC.US.md)
- [BeOne Medicines (688235.CN)](https://longbridge.com/en/quote/688235.CN.md)
- [BeiGene, Ltd. (BGNE.US)](https://longbridge.com/en/quote/BGNE.US.md)
- [BEONE MEDICINES (06160.HK)](https://longbridge.com/en/quote/06160.HK.md)

## Related News & Research

- [11:06 ETHow Dealerships Win 2026](https://longbridge.com/en/news/281648255.md)
- [XRP Price Hits a Reset Phase as Analyst Egrag Estimates that “an XRP Price Around $11 Would be Plausible”](https://longbridge.com/en/news/281634476.md)
- [--Emcor Keeps Quarterly Dividend at $0.40 a Share; Payable April 30 to Shareholders of Record as of April 16](https://longbridge.com/en/news/281548519.md)
- [13:11 ETEBSCOed Expands LER.me into a Free, Open-Access LER Talent Marketplace](https://longbridge.com/en/news/281405472.md)
- [Port Houston March 2026 Meeting: Project 11 Expansion Recognized for Engineering Excellence](https://longbridge.com/en/news/281435223.md)